Wednesday, July 8, 2026
🇺🇸 FDA

pharma · No medical condition. · Breast cancer

George Institute for

The George Institute

George Institute for clinical programs — 406 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Sydney, NSW 2042, AU
Founded
1999
Employees
841
Programs
406
Drugs
522
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Programs

George Institute for projects

406 ClinicalTrials.gov programs sponsored by George Institute for.

George Institute for has 406 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

406 programs

Clinical programs

Page 2 of 9

  1. KEEP-ON

    The George Institute

    Hyperkalemia in patients with chronic kidney disease

    phase 3 small molecule active

    1 trial

  2. Levetiracetam NORMON comprimidos recubiertos...

    The George Institute

    Down syndrome, Alzheimer's Disease

    phase 3 small molecule active

    1 trial

  3. METHYLPREDNISOLONE , ACETYLCYSTEINE

    The George Institute

    Acute Alcoholic hepatitis

    phase 3 small molecule active

    1 trial

  4. MHICC-2021-001

    The George Institute

    Type 2 diabetic patients with no prior cardiovascular (CV) events

    phase 3 small molecule active

    1 trial

  5. Metformina Uxa comprimidos recubiertos con pe...

    The George Institute

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 3 small molecule active

    1 trial

  6. Mirena 20 mikrogram/24 timmar intrauterint in...

    The George Institute

    Post medical abortion contraception

    phase 3 small molecule active

    1 trial

  7. Natriumklorid Braun /ml spädningsvätska för p... for Allergisk Rinit

    The George Institute

    Allergisk Rinit

    phase 3 small molecule active

    1 trial

  8. Niraparib tosylate monohydrate + abiraterone... for Prostate Cancer

    The George Institute

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  9. P01351

    The George Institute

    Chronic kidney disease

    phase 3 small molecule active

    1 trial

  10. P01351

    The George Institute

    Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  11. PI23/00797

    The George Institute

    Acute Heart Failure

    phase 3 small molecule active

    1 trial

  12. PROICM 2018-01 NEX

    The George Institute

    Metastatic colorectal cancer

    phase 3 small molecule active

    1 trial

  13. PROICM 2021-01 GRE

    The George Institute

    Rectum cancer

    phase 3 small molecule active

    1 trial

  14. Placebo capsules for bacterial sexually transmitted…

    The George Institute

    bacterial sexually transmitted infections

    phase 3 small molecule active

    1 trial

  15. RAMIRIS

    The George Institute

    advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctions, who failed prior line of palliative chemotherpay

    phase 3 small molecule active

    1 trial

  16. REACT

    The George Institute

    Community-acquired pneumonia

    phase 3 small molecule active

    1 trial

  17. RESPIRATORY SYNCYTIAL VIRUS VACCINES

    The George Institute

    RSV infection

    phase 3 small molecule active

    1 trial

  18. Rabipur Pulver und Lösungsmittel zur Herstell... for Rabies

    The George Institute

    Rabies

    phase 3 small molecule active

    1 trial

  19. Rabipur poeder en oplosmiddel voor oplossing... for Rabies

    The George Institute

    Rabies

    phase 3 small molecule active

    1 trial

  20. Rivaroxaban 2.5 Mg Oral Tablet

    The George Institute

    Chronic Kidney Diseases

    phase 3 small molecule completed

    1 trial

  21. S005201-175

    The George Institute

    Type 2 Diabetes inadequately controlled with dapagliflozin with or without metformin

    phase 3 small molecule active

    1 trial

  22. S095031-178

    The George Institute

    Hypomethylating agent (HMA) naive myelodysplastic syndromes Myelodysplastic Symdrome (MDS), Myelodysplastic Symdrome (MDS)

    phase 3 small molecule active

    1 trial

  23. SATURN

    The George Institute

    Spontaneous lobar ICH

    phase 3 small molecule active

    1 trial

  24. SEVOFLURANE, DEXMEDETOMIDINE HYDROCHLORIDE

    The George Institute

    Children under the age of 2 years having surgery lasting at least 2 hours

    phase 3 small molecule active

    1 trial

  25. SHIELD-PRP

    The George Institute

    CHRONIC OMALGIA

    phase 3 small molecule active

    1 trial

  26. SIMFIB

    The George Institute

    Fibrosis liber, chronic liver disease, alcoholic liver disease

    phase 3 small molecule active

    1 trial

  27. SMART-JIA

    The George Institute

    Juvenile Idiopathic Arthritis

    phase 3 small molecule active

    1 trial

  28. STAMARIL® for Yellow fever

    The George Institute

    Yellow fever

    phase 3 small molecule active

    1 trial

  29. STEMNESS-CRC

    The George Institute

    Histologically confirmed adenocarcinoma of the colon or rectum that is metastatic.

    phase 3 small molecule active

    1 trial

  30. STEMNESS-PANC

    The George Institute

    Histologically or cytologically confirmed advanced pancreatic adenocarcinoma that is metastatic.

    phase 3 small molecule active

    1 trial

  31. Skilarence gastro-resistant tablets for Adrenomyeloneuropathy

    The George Institute

    Adrenomyeloneuropathy

    phase 3 small molecule active

    1 trial

  32. Suspension of autologous mononuclear cells separated from bone marrow aspirate

    The George Institute

    diabetic foot syndrome, lower limb ischemia

    phase 3 small molecule active

    1 trial

  33. TRACK_001

    The George Institute

    Improvement of cardiovascular outcomes in patients with advanced chronic kidney disease. In easily understood language, this is Heart and blood vessel disease and Kidney disease.

    phase 3 small molecule active

    1 trial

  34. TRIGON DEPOT 40 mg/ml suspensión inyectable.

    The George Institute

    Chronic shoulder pain

    phase 3 small molecule active

    1 trial

  35. TROMALYT 150 mg cápsulas duras de liberación prolongada

    The George Institute

    Women infertility

    phase 3 small molecule active

    1 trial

  36. Tamoxifen Viatris 20 mg tabletter.

    The George Institute

    Breast Cancer

    phase 3 small molecule active

    1 trial

  37. Testosterone Gel 1% for low ovarian reserve according t…

    The George Institute

    low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

    phase 3 small molecule active

    1 trial

  38. The STARS trial

    The George Institute

    juvenile idiopathic arthritis

    phase 3 small molecule active

    1 trial

  39. The placebo tablet composition is: Collodial...

    The George Institute

    Colon and rectal cancer tumor stage II-III, tumor with somatic alterationsin PIK3CA, PIK3R1 or PTEN

    phase 3 small molecule active

    1 trial

  40. Tibsovo 250 mg film-coated tablets

    The George Institute

    ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma

    phase 3 small molecule active

    1 trial

  41. Trulicity 0.75 mg solution for injection in pre-filled pen

    The George Institute

    Preventive treatment of post-kidney transplant diabetes

    phase 3 small molecule active

    1 trial

  42. Trulicity 0.75 mg solution for injection in pre-filled pen

    The George Institute

    Metabolic syndrome in patients on the waiting list for kidney transplantation, Metabolic syndrome in patients on the waiting list for kidney transplantation

    phase 3 small molecule active

    1 trial

  43. URONCOR 06-24

    The George Institute

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  44. VACAB-2022

    The George Institute

    Patients with hip or knee infections

    phase 3 small molecule active

    1 trial

  45. Vanish Trial

    The George Institute

    People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.

    phase 3 small molecule active

    1 trial

  46. imPaCT-PRO-01

    The George Institute

    Thromboprophylaxis in patients with advanced pancreatic cancer

    phase 3 small molecule active

    1 trial

  47. -

    The George Institute

    Cytomegalovirus infection post allogeneic allogeneic HLA-identical familial PHT

    phase 2 small molecule active

    1 trial

  48. 2016/2369

    The George Institute

    pediatric cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does George Institute for have?

406 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.